These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 25791727)

  • 1. A National Study of Outcomes among HIV-Infected Kidney Transplant Recipients.
    Locke JE; Mehta S; Reed RD; MacLennan P; Massie A; Nellore A; Durand C; Segev DL
    J Am Soc Nephrol; 2015 Sep; 26(9):2222-9. PubMed ID: 25791727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus-Infected Recipients.
    Locke JE; Durand C; Reed RD; MacLennan PA; Mehta S; Massie A; Nellore A; DuBay D; Segev DL
    Transplantation; 2016 Jan; 100(1):141-6. PubMed ID: 26177090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection.
    Terrault NA; Roland ME; Schiano T; Dove L; Wong MT; Poordad F; Ragni MV; Barin B; Simon D; Olthoff KM; Johnson L; Stosor V; Jayaweera D; Fung J; Sherman KE; Subramanian A; Millis JM; Slakey D; Berg CL; Carlson L; Ferrell L; Stablein DM; Odim J; Fox L; Stock PG;
    Liver Transpl; 2012 Jun; 18(6):716-26. PubMed ID: 22328294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes in HIV+/HCV+ coinfected kidney transplant recipients in the pre- and post-direct-acting antiviral therapy eras: 10-Year single center experience.
    Camargo JF; Anjan S; Chin-Beckford N; Morris MI; Abbo LM; Simkins J; Ciancio G; Chen LJ; Burke GW; Figueiro J; Guerra G; Kupin WL; Mattiazzi A; Ortigosa-Goggins M; Ram Bhamidimarri K; Roth D
    Clin Transplant; 2019 May; 33(5):e13532. PubMed ID: 30866102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond the NIH Multicenter HIV Transplant Trial Experience: Outcomes of HIV+ Liver Transplant Recipients Compared to HCV+ or HIV+/HCV+ Coinfected Recipients in the United States.
    Sawinski D; Goldberg DS; Blumberg E; Abt PL; Bloom RD; Forde KA
    Clin Infect Dis; 2015 Oct; 61(7):1054-62. PubMed ID: 26082506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic kidney disease after liver transplantation in human immunodeficiency virus/hepatitis C virus-coinfected recipients versus human immunodeficiency virus-infected recipients without hepatitis C virus: results from the National Institutes of Health multi-site study.
    Bahirwani R; Barin B; Olthoff K; Stock P; Murphy B; Rajender Reddy K;
    Liver Transpl; 2013 Jun; 19(6):619-26. PubMed ID: 23512786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal transplantation in human immunodeficiency virus-infected recipients: a case-control study from the Brazilian experience.
    Vicari AR; Spuldaro F; Sandes-Freitas TV; Cristelli MP; Requião-Moura LR; Reusing JO; Pierrotti LC; Oliveira ML; Girão CM; Gadonski G; Kroth LV; Deboni LM; Ferreira GF; Tedesco-Silva H; Esmeraldo R; David-Neto E; Saitovitch D; Keitel E; Garcia VD; Pacheco-Silva A; Medina-Pestana JO; Manfro RC
    Transpl Infect Dis; 2016 Oct; 18(5):730-740. PubMed ID: 27503081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of immunosuppressive regimen on survival of kidney transplant recipients with hepatitis C.
    Luan FL; Schaubel DE; Zhang H; Jia X; Pelletier SJ; Port FK; Magee JC; Sung RS
    Transplantation; 2008 Jun; 85(11):1601-6. PubMed ID: 18551066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of orthotopic liver transplantation in human immunodeficiency virus-infected patients and comparison with human immunodeficiency virus-negative cases.
    Baccarani U; Adani GL; Bragantini F; Londero A; Comuzzi C; Rossetto A; Lorenzin D; Bresadola V; Risaliti A; Pea F; Toniutto P; Donini A; De Anna D; Bresadola F; Tavio M; Viale P
    Transplant Proc; 2011 May; 43(4):1119-22. PubMed ID: 21620067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney Transplantation in HIV-Infected Recipients: Encouraging Outcomes, but Registry Data Are No Longer Enough.
    Wright AJ; Gill JS
    J Am Soc Nephrol; 2015 Sep; 26(9):2070-1. PubMed ID: 25791726
    [No Abstract]   [Full Text] [Related]  

  • 11. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of hepatitis C virus viremia on renal graft and patient survival: a 9-year prospective study.
    Mahmoud IM; Elhabashi AF; Elsawy E; El-Husseini AA; Sheha GE; Sobh MA
    Am J Kidney Dis; 2004 Jan; 43(1):131-9. PubMed ID: 14712436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of hepatitis C virus donor and recipient status on long-term kidney transplant outcomes: University of Wisconsin experience.
    Singh N; Neidlinger N; Djamali A; Leverson G; Voss B; Sollinger HW; Pirsch JD
    Clin Transplant; 2012; 26(5):684-93. PubMed ID: 22283142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Optimal Donor-Recipient Combinations Among Human Immunodeficiency Virus (HIV)-Positive Kidney Transplant Recipients.
    Locke JE; Shelton BA; Reed RD; MacLennan PA; Mehta S; Sawinski D; Segev DL
    Am J Transplant; 2016 Aug; 16(8):2377-83. PubMed ID: 27140837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes and transmission rates in hepatitis C virus-positive donor to hepatitis C virus-negative kidney transplant recipients: Analysis of United States national data.
    Gupta G; Kang L; Yu JW; Limkemann AJ; Garcia V; Bandyopadhyay D; Kumar D; Fattah H; Levy M; Cotterell AH; Sharma A; Bhati C; Reichman T; King AL; Sterling R
    Clin Transplant; 2017 Oct; 31(10):. PubMed ID: 28712111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney transplantation in hepatitis C-positive recipients: does type of induction influence outcomes?
    Sureshkumar KK; Thai NL; Marcus RJ
    Transplant Proc; 2012 Jun; 44(5):1262-4. PubMed ID: 22663997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superior outcomes in HIV-positive kidney transplant patients compared with HCV-infected or HIV/HCV-coinfected recipients.
    Sawinski D; Forde KA; Eddinger K; Troxel AB; Blumberg E; Tebas P; Abt PL; Bloom RD
    Kidney Int; 2015 Aug; 88(2):341-9. PubMed ID: 25807035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival in HIV-positive transplant recipients compared with transplant candidates and with HIV-negative controls.
    Roland ME; Barin B; Huprikar S; Murphy B; Hanto DW; Blumberg E; Olthoff K; Simon D; Hardy WD; Beatty G; Stock PG;
    AIDS; 2016 Jan; 30(3):435-44. PubMed ID: 26765937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of preexisting hepatitis C virus antibody positivity in simultaneous pancreas-kidney transplant recipients.
    Miguel M; Sampaio MS; Kuo HT; Poommipanit N; Martin P; Bunnapradist S
    Transplantation; 2010 Jul; 90(1):61-7. PubMed ID: 20463638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved survival among sickle cell kidney transplant recipients in the recent era.
    Huang E; Parke C; Mehrnia A; Kamgar M; Pham PT; Danovitch G; Bunnapradist S
    Nephrol Dial Transplant; 2013 Apr; 28(4):1039-46. PubMed ID: 23345624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.